Abrysvo had previously been approved for adults 60-years and older.
FDA Approves Pfizer’s RSV Vaccine for Adults 18-59
Abrysvo had previously been approved for adults 60-years and older.
You may also like
Pharma Pulse 10/23/24: Women More Likely to Face...
Qnovia CEO to Speak at Public Meeting with FDA and NIH
Pharma Pulse 10/24/24: Safeguarding Customer Data...
Young & Partners Pharmaceutical Executive Summit...
Reese Pharmaceutical Launches Second Phase of...
Advantages & Disadvantages of Using Compounded...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.